BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32781781)

  • 1. Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C.
    Martos L; Oto J; Fernández-Pardo Á; Plana E; Solmoirago MJ; Cana F; Hervás D; Bonanad S; Ferrando F; España F; Navarro S; Medina P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
    Navarro S; Medina P; Bonet E; Corral J; Martínez-Sales V; Martos L; Rivera M; Roselló-Lletí E; Alberca I; Roldán V; Mira Y; Ferrando F; Estellés A; Vicente V; Bertina RM; España F
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1435-40. PubMed ID: 23520161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
    Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C inhibits neutrophil extracellular trap formation
    Healy LD; Puy C; Fernández JA; Mitrugno A; Keshari RS; Taku NA; Chu TT; Xu X; Gruber A; Lupu F; Griffin JH; McCarty OJT
    J Biol Chem; 2017 May; 292(21):8616-8629. PubMed ID: 28408624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of two haplotypes of the human endothelial protein C receptor gene.
    Medina P; Navarro S; Bonet E; Martos L; Estellés A; Bertina RM; Vos HL; España F
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):684-90. PubMed ID: 24436369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.
    Uitte de Willige S; Van Marion V; Rosendaal FR; Vos HL; de Visser MC; Bertina RM
    J Thromb Haemost; 2004 Aug; 2(8):1305-10. PubMed ID: 15304035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk.
    Medina P; Navarro S; Estellés A; Vayá A; Woodhams B; Mira Y; Villa P; Migaud-Fressart M; Ferrando F; Aznar J; Bertina RM; España F
    Thromb Haemost; 2004 May; 91(5):905-11. PubMed ID: 15116250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels.
    Medina P; Bonet E; Navarro S; Martos L; Estellés A; Ferrando F; Vicente V; Bertina RM; España F
    Thromb Haemost; 2012 Mar; 107(3):448-57. PubMed ID: 22273845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited abnormalities in the protein C activation pathway.
    España F; Medina P; Navarro S; Estellés A; Aznar J
    Pathophysiol Haemost Thromb; 2002; 32(5-6):241-4. PubMed ID: 13679649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.
    Rühl H; Berens C; Winterhagen FI; Reda S; Müller J; Oldenburg J; Pötzsch B
    Circ Res; 2019 Aug; 125(5):523-534. PubMed ID: 31314700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts.
    Smith P; Rosell A; Farm M; Bruzelius M; Aguilera Gatica K; Mackman N; Odeberg J; Thålin C
    PLoS One; 2022; 17(7):e0270865. PubMed ID: 35901107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
    Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
    Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism.
    Wu C; Dwivedi DJ; Pepler L; Lysov Z; Waye J; Julian J; Desch K; Ginsburg D; Weitz JI; Kearon C; Liaw PC
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2674-81. PubMed ID: 24051141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three polymorphisms in promoter of protein C gene with endothelial protein c receptor gene and risk of venous thrombosis.
    Horakova K; Kolorz M; Bartosova L; Pechacek V; Wroblova K
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):814-7. PubMed ID: 24158116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C.
    Díez N; Montes R; Alonso A; Medina P; Navarro S; España F; Hermida J
    J Thromb Haemost; 2006 Feb; 4(2):398-402. PubMed ID: 16420572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study.
    Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
    J Thromb Haemost; 2022 Apr; 20(4):929-935. PubMed ID: 34970867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
    Petito E; Falcinelli E; Paliani U; Cesari E; Vaudo G; Sebastiano M; Cerotto V; Guglielmini G; Gori F; Malvestiti M; Becattini C; Paciullo F; De Robertis E; Bury L; Lazzarini T; Gresele P;
    J Infect Dis; 2021 Mar; 223(6):933-944. PubMed ID: 33280009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.
    Heinemann LA; Assmann A; Spannagl M; Schramm W; Dick A; Kluft C; de Maat MP
    Contraception; 1998 Nov; 58(5):321-2. PubMed ID: 9883389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.